← Back to Search

Behavioral Intervention

Intervention group for Schizoaffective Disorder

N/A
Recruiting
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention
Awards & highlights

Study Summary

This trial aims to test a new program to help people with serious mental illness become more active and involved in their communities. Participants will attend weekly online sessions for 10 weeks and then monthly sessions for

Who is the study for?
This trial is for individuals with serious mental illnesses like Schizoaffective Disorder, Schizophrenia, various forms of Depression, Bipolar Disorder, Psychosis, and Mood Disorders. Participants should be willing to engage in online sessions and use a GPS app to track movement.Check my eligibility
What is being tested?
The study tests Behavioral Activation intervention aimed at increasing activity variety and community participation among the mentally ill. It involves weekly online sessions for 10 weeks followed by monthly check-ins over three months.See study design
What are the potential side effects?
Since this is a behavioral intervention rather than a medication or medical procedure, traditional side effects are not expected. However, participants may experience changes in mood or stress due to new activities or increased social interactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Activity Logs
Behavior Activation for Depression Scale
Community Mobility (Global Positioning System; GPS)
+2 more
Secondary outcome measures
Activity Assessment Scale
Capabilities and Opportunities for Participation Questionnaire
Habit Strength Scale
+10 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention groupExperimental Treatment1 Intervention
All participants will receive an online behavioral intervention for 10 weeks, followed by monthly maintenance sessions for 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavior Activation
2014
N/A
~60

Find a Location

Who is running the clinical trial?

National Institute on Disability, Independent Living, and Rehabilitation ResearchFED
71 Previous Clinical Trials
9,077 Total Patients Enrolled
Temple UniversityLead Sponsor
297 Previous Clinical Trials
82,921 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"As per the details on clinicaltrials.gov, this investigation is actively seeking volunteers. It was originally posted on February 15th, 2024 and most recently revised on March 27th of the same year."

Answered by AI

What is the current number of individuals being admitted into this particular medical trial?

"Indeed, as per details on clinicaltrials.gov, this trial is actively seeking participants. The trial was initially made public on February 15th, 2024 and underwent its most recent revision on March 27th of the same year. Enrollment aims to include a total of 52 patients at one designated site."

Answered by AI

What are the main goals that this clinical trial aims to achieve?

"The main objective of this clinical trial, which will be observed three times over two-week intervals: initially, within one month post the 10 weekly sessions, and then again three months following the end of the intervention is to document participants' Activity Logs. Secondary aims include evaluating loneliness using the University of California Los Angeles Loneliness Scale that features questions specifically for individuals acknowledging a mental health condition. The scale gauges feelings of social isolation or loneliness with response options varying from "hardly ever" (1) to "often" (3). Higher scores indicate increased loneliness while lower ratings suggest less solitude. Additionally, readiness for change is assessed by the"

Answered by AI
~35 spots leftby Aug 2026